Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

HPB Surgery

Volumn 2016, Issue , 2016, Pages

  Ahmed, Saleem ^a,b   De Souza, Nurun Nisa ^c,d   Qiao, Wang ^b   Kasai, Meidai ^e   Keem, Low Jee ^a   Shelat, Vishal G ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b MINISTRY OF HEALTH   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^e SENDAI KOUSEI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84965118850     PISSN: 08948569     EISSN: 16078462     Source Type: Journal    
DOI: 10.1155/2016/6120143     Document Type: Article

References (43)

1. F. X. Bosch, J. Ribes, R. Cléries, and M. Díaz, "Epidemiology of hepatocellular carcinoma, " Clinics in Liver Disease, vol. 9, no. 2, pp. 191-211, 2005.
2. R. Salem, M. Gilbertsen, Z. Butt et al. , "Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization, " Clinical Gastroenterology and Hepatology, vol. 11, no. 10, pp. 1358. e1-1365. e1, 2013.
3. N. Heffernan, D. Cella, K. Webster et al. , "Measuring healthrelated quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire, " Journal of Clinical Oncology, vol. 20, no. 9, pp. 2229-2239, 2002.
4. K. Takayasu, S. Arii, I. Ikai et al. , "Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients, " Gastroenterology, vol. 131, no. 2, pp. 461-469, 2006.
5. European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer, "EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma, " Journal of Hepatology, vol. 56, no. 4, pp. 908-943, 2012.
6. J. Bruix and M. Sherman, "Management of hepatocellular carcinoma: an update, " Hepatology, vol. 53, no. 3, pp. 1020-1022, 2011.
7. J. M. Llovet and J. Bruix, "Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival, " Hepatology, vol. 37, no. 2, pp. 429-442, 2003.
8. S. Gandhi, S. Khubchandani, and R. Iyer, "Quality of life and hepatocellular carcinoma, " Journal of Gastrointestinal Oncology, vol. 5, no. 4, pp. 296-317, 2014.
9. H. Toyoda, S. Nakano, I. Takeda et al. , "The study of continuous local arterial-infusion chemotherapy with 5-FU + CDDP for patients with severely advancedHCC-for the elongation of the life-span and the improvement of QOL, "Gan To Kagaku Ryoho, vol. 20, no. 11, pp. 1495-1498, 1993.
10. G. Tanabe, S. Ueno, M. Maemura et al. , "Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma, " Hepato-Gastroenterology, vol. 48, no. 38, pp. 506-510, 2001.
11. N. Heffernan, D. Cella, K. Webster et al. , "Measuring healthrelated quality of life in patients with hepatobiliary cancers: the functional assessment of Cancer Therapy-Hepatobiliary Questionnaire, " Journal of Clinical Oncology, vol. 20, no. 9, pp. 2229-2239, 2002.
12. D. F. Cella, D. S. Tulsky, G. Gray et al. , "The functional assessment of cancer therapy scale: development and validation of the general measure, " Journal of Clinical Oncology, vol. 11, no. 3, pp. 570-579, 1993.
13. "Development of the World Health Organization WHOQOLBREF quality of life assessment. The WHOQOL Group, " Psychological Medicine, vol. 28, no. 3, pp. 551-558, 1998.
14. J. E. Ware, K. K. Snow, M. Kosinski, and B. Gandek, SF-36Health Survey, NewEnglandMedicalCenterHospital, Health Institute, 1993.
15. J. E. Ware Jr. , M. Kosinski, and S. D. Keller, "A 12-item shortformhealth survey: construction of scales and preliminary tests of reliability and validity, " Medical Care, vol. 34, no. 3, pp. 220-233, 1996.
16. B. F. Piper, S. L. Dibble, M. J. Dodd, M. C. Weiss, R. E. Slaughter, and S. M. Paul, "The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer, " Oncology Nursing Forum, vol. 25, no. 4, pp. 677-684, 1998.
17. S. Holmes, "Use of a modified symptom distress scale in assessment of the cancer patient, " International Journal of Nursing Studies, vol. 26, no. 1, pp. 69-79, 1989.
18. A. S. Zigmond and R. P. Snaith, "The hospital anxiety and depression scale, " Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361-370, 1983.
19. T. Kato, M. Niwa, Y. Saito et al. , "Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma, " Gan To Kagaku Ryoho, vol. 17, no. 8, pp. 1623-1628, 1990.
20. Z. Jianbo, L. Yanhao, C. Yong et al. , "Evaluation of quality of life before and after interventional therapy in patients with primary hepatocellular carcinoma, " Chinese Journal of Radiology, vol. 36, no. 10, pp. 873-876, 2002.
21. J. Steel, A. Baum, and B. Carr, "Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin versus 90-Yttrium microspheres (Therasphere -), " Psycho-Oncology, vol. 13, no. 2, pp. 73-79, 2004.
22. S.-C. Shun, Y.-H. Lai, T.-T. Jing et al. , "Fatigue patterns and correlates in male liver cancer patients receiving transcatheter hepatic arterial chemoembolization, " Supportive Care in Cancer, vol. 13, no. 5, pp. 311-317, 2005.
23. Y.-B. Wang, M.-H. Chen, K. Yan, W. Yang, Y. Dai, and S.-S. Yin, "Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone, " Quality of Life Research, vol. 16, no. 3, pp. 389-397, 2007.
24. B. C. Wible, W. S. Rilling, P. Drescher et al. , "Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization, " Journal of Vascular and Interventional Radiology, vol. 21, no. 7, pp. 1024-1030, 2010.
25. A. Toro, E. Pulvirenti, F. Palermo, and I. Di Carlo, "Healthrelated quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment, " Surgical Oncology, vol. 21, no. 1, pp. e23-e30, 2012.
26. S.-C. Shun, C.-H. Chen, J.-C. Sheu, J.-D. Liang, J.-C. Yang, and Y.-H. Lai, "Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study, " Oncologist, vol. 17, no. 5, pp. 732-739, 2012.
27. K. M. Eltawil, R. Berry, M. Abdolell, and M. Molinari, "Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study, " HPB, vol. 14, no. 5, pp. 341-350, 2012.
28. Z. R. Xie, Y. L. Luo, F. M. Xiao, Q. Liu, and Y. Ma, "Health-related quality of life of patients with intermediate hepatocellular carcinoma after liver resection or transcatheter arterial chemoembolization, " Asian Pacific Journal of Cancer Prevention, vol. 16, no. 10, pp. 4451-4456, 2015.
29. M. Xing, G. Webber, H. J. Prajapati et al. , "Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: longitudinal prospective study, " Journal of Gastroenterology and Hepatology, vol. 30, no. 7, pp. 1167-1174, 2015.
30. L. Hopp, "Risk of bias reporting in Cochrane systematic reviews, " International Journal of Nursing Practice, vol. 5, pp. 683-686, 21.
31. T. M. Gill and A. R. Feinstein, "A critical appraisal of the quality of quality-of-life measurements, " The Journal of the American Medical Association, vol. 272, no. 8, pp. 619-626, 1994.
32. B. Ferrell, M. Grant, G. Padilla, S. Vemuri, and M. Rhiner, "The experience of pain and perceptions of quality of life: validation of a conceptual model, " Hospice Journal, vol. 7, no. 3, pp. 9-24, 1991.
33. B. R. Ferrell, C. Wisdom, and C. Wenzl, "Quality of life as an outcome variable in the management of cancer pain, " Cancer, vol. 63, no. 11, pp. 2321-2327, 1989.
34. B. R. Ferrell, "The impact of pain on quality of life. A decade of research, " The Nursing Clinics of North America, vol. 30, no. 4, pp. 609-624, 1995.
35. B. R. Ferrell, K. H. Dow, and M. Grant, "Measurement of the quality of life in cancer survivors, " Quality of Life Research, vol. 4, no. 6, pp. 523-531, 1995.
36. Y.-S. Guan, Q. He, and M.-Q. Wang, "Transcatheter arterial chemoembolization: history for more than 30 years, " ISRN Gastroenterology, vol. 2012, Article ID 480650, 8 pages, 2012.
37. S. W. Shin, "The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma, " Korean Journal of Radiology, vol. 10, no. 5, pp. 425-434, 2009.
38. S. Kaasa and J. H. Loge, "Quality-of-life assessment in palliative care, " The Lancet Oncology, vol. 3, no. 3, pp. 175-182, 2002.
39. L. D. MacKeigan and D. S. Pathak, "Overview of healthrelated quality-of-life measures, " American Journal of Hospital Pharmacy, vol. 49, no. 9, pp. 2236-2245, 1992.
40. A. E. T. Yeo and C. R. Berney, "Carolinas comfort scale for mesh repair of inguinal hernia, " ANZ Journal of Surgery, vol. 82, no. 4, pp. 285-286, 2012.
41. Mapi Research Trust, "PROQOLID, the Clinical Outcome Assessment (COA) Instruments Database, " http://www. proqolid. org/.
42. M. L. Slevin, "Quality of life: philosophical question or clinical reality" BritishMedical Journal, vol. 305, no. 6851, pp. 466-469, 1992.
43. J. M. Blazeby, E. Currie, B. C. Y. Zee, W.-C. Chie, R. T. Poon, and O. J. Garden, "Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQHCC18, " European Journal of Cancer, vol. 40, no. 16, pp. 2439-2444, 2004.